Valneva
Karin Kosulin has a diverse work experience in scientific research. Karin worked as a Scientist and Project Lead at Valneva starting in December 2020. Prior to that, they served as a Postdoctoral Researcher at St. Anna Kinderkrebsforschung (Children's Cancer Research Institute - CCRI) from August 2013 to November 2020. Karin also worked as a Postdoctoral Researcher at Heinrich Pette Institute, Leibniz Institute for Experimental Virology (HPI) from September 2009 to June 2013, and at St. Anna Kinderkrebsforschung (Children's Cancer Research Institute - CCRI) from May 2005 to June 2009.
Karin Kosulin's education history begins in 1993 when they enrolled at the University of Natural Resources and Life Sciences, Vienna (BOKU) for their Master's degree (Dipl.Ing.), which they completed in 2000. Karin continued their studies at BOKU and obtained their Ph.D. (Doktor) from the University of Natural Resources and Life Sciences, Vienna in 2005. In 2021, Karin Kosulin pursued further specialization by studying Virology at the Medical University of Vienna, where they currently hold the title of Privatdozentin.
This person is not in any offices
Valneva
3 followers
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.